Depression detection via speech: new tool shows promise
NCT ID NCT06044818
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a speech analysis tool called acceXible can help screen for and monitor major depressive disorder. Researchers analyzed voice recordings from 166 adults as they described images. The goal was to see if changes in speech patterns relate to depression. If validated, this could offer a quick, remote way to assess mental health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Speech analysis device
- What this could lead to
- If successful, this could provide a simple, non-invasive tool to help doctors screen for and track depression using just a voice recording.
- What could go wrong
- This is a completed validation study, not a treatment trial. The tool may not be accurate enough for widespread use, and results may not apply to non-Spanish speakers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vall d'Hebron Institut de Investigación (VHIR)
Barcelona, Barcelona, 08035, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can couples counseling lift depression in women?
- Brain wave clues: could inflammation markers forecast ECT outcomes?
- Can tailored brain zaps beat standard therapy for depression?
- Can a new daily pill lift the fog of depression?
- Can a new pill outsmart depression? a trial puts KH607 to the test
- Depression's biological fingerprint: a quest for objective diagnosis and personalized treatment